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1. INTRODUCTION
Botulism, a potentially fatal neuroparalytic disease, is caused by 
highly potent neurotoxins produced by the Gram-positive, anaerobic 
spore-forming bacteria, Clostridium botulinum, Clostridium barati, 
Clostridium butyricum, Clostridium sporogenes and Clostridium 
argentinense [1,2]. The clostridial species can produce up to seven 
antigenically distinct exotoxins (A, B, C1, D, E, F and G), which are 
differentiated serologically by specific antitoxin. Types A, B, E, and 
more rarely F, are responsible for most human cases [3]. Botulinum 
Neurotoxin (BoNT) blocks evoked quantal acetylcholine release 
from motor ending at all peripheral cholinergic synapses, producing 
a profound but transient muscle flaccid paralysis [4]. If remained 
untreated, a severe case of botulism leads to death of the patient due 
to paralysis of the respiratory muscles [5].
Food-borne botulism, the most widely recognized form, is caused by 
eating food containing BoNT [6]. Since C. botulinum is ubiquitous 
in the environment, spores routinely contaminate food and sur-
vive by standard cooking practices that do not surpass 100°C. 
Clostridium botulinum produce botulinum toxin under specific 
conditions that incorporate an anaerobic, low-acid and -salt envi-
ronment. Home-preserved foods regularly achieve these condi-
tions, and therefore, present a high risk for botulism.
Regardless of the form or serotypes involved, nonetheless, human 
botulism is a medical crisis that requires rapid intervention. 
Because prompt administration of antitoxin can reduce the severity 
of the disease [7], the choice for treatment depends on clinical diag-
nosis and epidemiologic data, without laboratory confirmation. 
Along the world, there are many reports on food-borne botulism 
due to the consumption of traditional salted fish, dairy products 
such as cheese and kashk, and canned foods in Iran [8,9]. Different 
sorts of fish; smoked, salted, and canned, additionally canned green 
beans and cucumber are causative agents of food-borne botulism 
recorded in some medical centers in Tehran and various regions 
of Iran, between April 1984 and August 1994 [10]. Examination 
of food-borne botulism incidents provides valuable data in 
regards to implicated foods and conditions resulting in toxin for-
mation. In order to identify outbreaks as rapidly as possible, the 
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Background: Botulism is a severe neuroparalytic disease caused by toxins produced by several Clostridium species. This work 
presents the surveillance results of botulism in Iran, with the distribution of the cases by regions and by vehicle of transmission.
Methods: We describe the findings of the Centers for Disease Control and Prevention (CDC) surveillance on 2037 suspected 
cases of food-borne botulism during 2007–2017.
Results: A total of 252 (12.3%) cases were confirmed to food-borne botulism. The mean annual incidence per 100,000 
Iranian Natives was 7.1 cases for male individuals and 3.3 cases for female individuals. All botulism events were confirmed to 
be foodborne. The most commonly implicated food was home-prepared traditional processed fish product, followed by the 
consumption of commercially canned products and non-pasteurized dairy products. Forty-eight (19%) fatal botulism were 
reported which, the case-fatality rate declined from 4.5% to 0.7% during the study period.
Conclusion: Laboratory-based diagnosis of botulism is an imperative procedure to elucidate cases, particularly food-borne 
botulism, to identify toxins in food and confirm clinical diagnosis, helping sanitary control measures. In addition, educational 
materials related to botulism prevention should be disseminated to different communities.
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Table 1 | Number of confirmed and suspected cases of foodborne 
botulism by year, Iran, 2007–2017
Year
Confirmed case Suspected case Fatality rate
No. (%) No. (%) No. (%)
2007 0 (0) 16 (100) 1 (6.2)
2008 2 (3.2) 40 (64.5) 2 (3.2)
2009 1 (1.1) 84 (98.8) 1 (1.1)
2010 45 (16.7) 164 (61.1) 10 (3.7)
2011 83 (18.6) 279 (62.8) 26 (5.8)
2012 24 (16) 85 (56.6) 4 (2.6)
2013 17 (15.1) 70 (62.5) 4 (3.5)
2014 27 (10.3) 2 (0.7) 0 (0)
2015 18 (5.9) 1 (0.3) 0 (0)
2016 24 (13.4) 1 (0.5) 0 (0)
2017 11 (6.9) 1 (0.6) 0 (0)
Annual mean 22.9 67.5 4.3
Total 252 743 48
Centers for Disease Control and Prevention (CDC) maintain an 
intensive National Botulism Surveillance System, provide epidemi-
ologic consultation and laboratory diagnostic services, and admin-
ister the antitoxin release process. In order to collect and analyze 
data, the Iranian national care system for botulism was designed 
and implemented in 2003. In addition, the epidemiological survey 
and immediate report of this disease to the health centers are 
underlined by the CDC. This study aimed to retrospectively inves-
tigate the changes of epidemiology, clinical and laboratory diagno-
sis of all suspected and laboratory-confirmed cases of food-borne 
botulism in Iran over a period of 11 years (2007–2017) following 
major political and economic changes, addressing the question of 
whether botulism is still an important health concern in Iran.
2. MATERIALS AND METHODS
The information exhibited in this study refer to the cases of botu-
lism reported to the Iran’s CDC within periods of 2007–2017. The 
present reporting system provides for the immediate notification of 
any case of botulism, even if only suspected, from the physician to 
the Local Health Authority; the flow proceeds toward the Region, 
the Ministry of Health (MOH), the National Institute of Health. 
For the transmission of the results of laboratory testing, either pos-
itive or negative, the similar flow is done. The diagnosis of botu-
lism was verified on epidemiological data and a clinical evidence 
of severity according to Public Health Agency of Canada. These 
signs and symptoms were: (1) Problems of accommodation (visual 
impairment); (2) dryness of the mouth (dry syndrome); (3) retarded 
intestinal transit; (4) dysphagia with liquid and/or solid meals; (5) 
persistent constipation; (6) urinary symptoms; (7) asthenia; (8) 
respiratory paralysis; and (9) peripheral paralysis and impossibility 
of oral feeding. Clinical samples include serum (10 mL), vomitus 
or gastric secretions, stool and suspect foods in original containers 
that were evaluated for toxin or C. botulinum [8]. Botulinum toxin 
was detected by bioassay. Toxin detection and identification by 
toxin neutralization tests in mice (mouse bioassay) was performed 
in a limited number of public health labs [11]. In addition to cases 
with laboratory confirmation, persons with botulism who were epi-
demiologically linked to a laboratory-confirmed case were consid-
ered to have confirmed, and thus reportable cases.
Demographics and disease information including age, gender, 
occupation, place of residence (urban or rural), town/city, type of 
toxic agent, month, season outcome (recovery or death), antitoxin 
administration, signs and symptoms were documented by a base-
line questionnaire [12]. Every one of this information, together 
with the lab and microbiological analysis results are collected and 
stored in a special database, which transmits all information to the 
MOH yearly. The gathered information was coded, computerized 
and analyzed utilizing SPSS software by univariate examination 
with t-tests and Chi-squared, as appropriate. For all tests, signifi-
cance was defined as p < 0.05.
3. RESULTS
3.1. Demographics and Incidence
During the period 2007–2017, 2037 cases suspected to food-borne 
botulism were reported, including 252 (12.3%) confirmed and 743 
(36.4%) cases were remained suspect to botulism (Table 1). Almost 
all patients (99.3%) were identified as Iranian Native. The mean 
annual number of cases was 185.1 (range, 16–444 cases per year). 
About 44% (914 of 2037) of the reported cases and 18.6% (47 of 
252) of confirmed cases were female. Most of the reported cases 
were laborers and people with limited formal education 672 (33%), 
housewife 635 (31.2%) or students 334 (16.4%). The next largest 
groups were: children 205 (10.1%), intellectuals and office work-
ers 109 (5.4%). However, most of the confirmed cases were house-
wife 66 (26.1%), children 54 (21.4%), farmer workers 37 (14.6%) 
and students 32 (12.6%). The profession for other patients was not 
specified in the medical records. Overall median age was 28.4 years 
(range, 2 months to 88 years).
During 2007–2017, the mean annual incidence per 100,000 Iranian 
Natives was 7.1 and 3.3 cases for male and female individuals, 
respectively. The incidence was not associated with age group 
(p > 0.05); patient’s age increased from 2007–2012 (median age, 25.2 
years) to 2013–2017 (median age, 31.5 years; p < 0.05). About 35% 
(398 of 1117) suspected cases occurred in urban areas accounting 
for an incidence rate of 4.2 patients per 100,000 urban inhabitants. 
Data is not available for other 920 individuals.
3.2. Morbidity and Mortality
The percentage of confirmed cases hospitalized during 2007–2012 
(88%) was similar to the percentage of patients hospitalized during 
2013–2017 (87%). During the study period, 81% of the botulism 
patients had received Intravenous (I.V) or Intramuscular (I.M) 
antitoxin types A, B, and E. These administration have occurred at 
a median of 1 day (mean, 1.37 days) after illness onset when bot-
ulism was initially suspected and a median of 3 days (mean, 3.11 
days) when botulism was initially misdiagnosed (p < 0.05). In addi-
tion, 38% (96 of 252) had received mechanical ventilatory support. 
Data regarding underlying medical conditions, adverse reactions to 
antitoxin, and overall duration of illness were unavailable.
The mouse bioassay is done in a limited number of public health 
labs. From the time that mice are injected, final results may not be 
available for 24 or 48 h. Likewise, all management decisions and 
initial public health interventions are determined based solely on 
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clinical diagnosis. Botulism was suspected at the initial clinical 
presentation for 79% of the cases. However, initial misdiagnosis 
occurred in 31% of cases. The clinical pattern was mainly charac-
terized by dry mouth 154 (61.1%), vomiting 151 (59.9%), double 
and/or blurred vision 92 (36.5%), constipation 75 (29.7%), droop-
ing eyelids 74 (29.4%), dysphagia 59 (23.4%), abdominal pain 
58 (23.0%), slurred speech 47 (18.6%), and mydriasis 34 (13.4%). 
When botulism was not suspected, the initial diagnosis was fre-
quently a gastrointestinal illness, encephalitis respiratory illness, or 
signs of poisoning with chemical pesticides.
About 19% (48 of 252) fatal botulism were reported during 2007–
2017, which was not significantly different among different age 
groups (Table 1). Within the 11-year study period, the case-fatality 
rate declined from 4.5% in 2007–2011 to 0.7% in 2012 2013 and 
then remained zero during the remaining years (Table 1). However, 
since mortality data were gotten from the lab databases that do not 
officially keep mortality records, these data should be interpreted 
with caution. Data regarding the association between type of botu-
lism and case fatality rate are not available.
3.3. Implicated Foods
All botulism events include confirmed or suspected cases were con-
firmed to be foodborne. The most commonly implicated food was 
home-prepared traditional processed fish (smoked fish, salted fish, 
ham, bacon, blood pudding, mosaic salami, sausage), accounting 
for 34.1% events. Other implicated food was commercially canned 
fish (28.6%), fish spawn (10.5%), diary product (10.1%), vegeta-
bles and home-prepared legumes (9.7%), cottage cheese (5.9%), 
and canned fruits (1.1%). Botulism events varied by season; most 
occurred in the spring (37.4%) or summer (33.0%), compared with 
winter (16.4%) and autumn (13.1%). About 18% of patients had a 
history of travel to other cities or provinces.
4. DISCUSSION
Food-borne botulism remains a potentially fatal public health risk 
among Iranian Native persons [13,14]. The annual mean of 26.2 
confirmed botulism cases during 2007–2011 was greater than 
reported cases during the 2012–2017 period; also, the case-fatality 
rate dramatically decreased from 15.8% to 3.1%, respectively. 
The recent decrease illustrates the impact of statewide prevention 
efforts and increased awareness of symptoms in high-risk commu-
nities, which leads to prompt medical attention and the administra-
tion of antitoxin. Across time, botulism incidence among Iranian 
individual remained higher among the male population, and occur-
rence of outbreaks peaked during spring and summer [15]. This 
higher rate of botulism poisoning in men is probably because of 
the cultural differences between them; men are more willing to eat 
canned foods and are less likely to heat food [16]. The seasonality of 
botulism outbreaks has been described previously [17] and is prob-
ably related to warmer temperatures and seasonal dietary variations.
Food consumption practices were also assessed in our survey. 
The primary cause of the disease was the consumption of home- 
prepared traditional processed fish and fish product, followed 
by the consumption of commercially canned products and non- 
pasteurized dairy products. Consumption of these foods either 
cooked or raw may contribute to food-borne toxicity in popula-
tions. A retrospective survey on food-borne botulism poisoning 
cases at north of Iran during 2001–2006 showed that conserved 
foods (38.7%), salted caviar (32.3%), and fish (16.3%) were the 
main causes of botulism, respectively [16]. Additionally, it was 
mentioned that anti-botulism is administered too hasty for some 
patients. Although, usually, in the empirical disease management, 
there was no escape from this snaps. Another survey of C. botuli-
num toxins in Iranian traditional food products indicate that some 
Iranian traditional foods (cheese and salted fish) may contaminated 
by different types of C. botulinum [8]. In their study, toxins were 
detected in 4.58% of analyzed samples (6.36% of salted fish samples 
and 3.51% of cheese samples). In a report from the Pasteur Institute, 
27 people in Qazvin province were affected after consuming 
traditional cheese and botulinum toxin (type A) was detected in 10 
patients [18]. Hydarnia and Memarbashi [19] showed the presence 
of botulinum toxin in traditional kashk (kind of dairy product in 
Iran). After this study, the Iranian Health Ministry decreed that all 
kashk for sale in Iran had to be pasteurized.
During 2002–2007 (6-year period), 260 cases of botulism were 
detected in Iran, of which 38 cases were related to the consump-
tion of traditional dairy products and 88 cases to the consumption 
of salted sea food [20]. In the similar period, another examination 
was performed to determine the rate of food-borne botulism ill-
ness [13]. It was reported that among 341 suspected cases of botu-
lism, the most and the least cases related to the years 2007 (28.28%) 
and 2003 (12.6%), respectively. Among the regions, Guilan lead 
the cases with 90 occasions while the least amount related to West 
Azerbaijan with four instances. Salin fish and spawn (31.08 %) were 
the most botulism producing factors. One of the most predominant 
causes of food poisoning (53.07%) was providing and consump-
tion of canned foods at home. Additionally, A and E types with 
the rate of (18–47%) and (13.7–41.3%), respectively were the most 
common causes of engendering botulism food poisoning [13]. 
This kind of food poisoning had an escalation probably because of 
paying more attention to record and reports of the occurred cases 
in recent years in comparison with what was used to be. It appears 
to be important to suggest the restaurants of this regions that serve 
fish and salted caviar in their menu list of foods to observe sanita-
tion rules to prevent botulism due to fish contamination and the 
greater role of aquaculture in causing this disease. It is also nec-
essary to hold courses on early detection and on time referral for 
physicians. Some measures like general health education, not using 
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unsanitary and traditional food processing, heating sufficient while 
consumption, not using unpasteurized dairy product, and regular 
supervising by health inspector can prevent claimed issue.
Botulism is relatively rare, thus some physicians are unfamiliar 
with the disease. Therefore, patients with botulism can be misdiag-
nosed as having other illnesses such as Guillain-Barré Syndrome, 
Miller-Fisher Syndrome and myasthenia gravis, resulting in delays 
in the administration of botulinum antitoxin and increased mor-
tality [21]. Although botulism is typically rare, fatality can be high 
if the disease is not treated immediately. The high mortality rate 
is related to delayed clinical diagnosis, and respiratory failure 
is a major cause of death. A significant reduction in mortality is 
observed when patients are treated in hospital units with intensive 
therapy [22].
Laboratory-based diagnosis of botulism is a fundamental basis 
for elucidating cases, particularly food-borne cases, affirming the 
clinical diagnosis and identifying toxins in food, allowing for epi-
demiologic surveillance for sanitary control measures. Although 
micro-organism culture methods can be applied for the isolation of 
viable cells of C. botulinum in clinical samples or food, they are not 
adequate to confirm the reason of illness, requiring interpretation 
of the results related to case definition in the epidemiologic investi-
gation. The demonstration of C. botulinum in patient stool samples 
or in cultures of wound material is generally satisfactory for the 
diagnosis of adult botulism syndromes and is considered definitive 
for the diagnosis of infant botulism [3].
Preparation of appropriate samples (depending on the type of bot-
ulism) before administration of antitoxin can lead to an increase in 
the number of positive cases of the specimens. It should be noted 
that compared with the industrialized countries, the percentage of 
positive samples in Iran is very low, showing that there are seri-
ous problems in the following areas: (1) Weakness in identifying 
suspected cases of botulism; (2) preparation of required samples 
before administration of antitoxin; (3) the inadequacy of the sam-
ples in terms of the quantities required for testing; (4) delay in the 
timely delivery of samples and failure to comply with standard 
conditions in their submission; (5) preparation and provision of 
anti-toxins A, B, and E are another common problem that we face 
in the treatment of patients. However, in recent years, improved 
national care system for botulism has increased the speed and 
accuracy of diagnosis and increased awareness-based care has also 
led to a reduction in incidence, rapid diagnosis of the onset and 
reduction of death.
In conclusion, the results of this investigation show that different 
types of C. botulinum may be present in Iranian traditional food 
products. Since these products are consumed raw or under-cooked, 
consumption of them may pose a risk of food-borne botulism 
in the Iranian population. Improved methods to reduce the risk 
for food-borne botulism and support behavior change should be 
explored. In addition, educational materials related to botulism 
prevention should be disseminated to different Iranian communi-
ties each spring, with messaging that targets the population and 
younger persons.
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